Eunjeong Kim

Eunjeong Kim practices at Surgery Center Palo Alto in Palo Alto, California.

Eunjeong Kim's NPI, 1104147834, was assigned on June 16, 2010. Eunjeong Kim graduated from Boston University School Of Medicine in 2010. Eunjeong Kim holds California license 161592.

Eunjeong Kim's primary practice is Surgery Center Palo Alto, at 795 El Camino Real, Palo Alto, CA 94301. The practice phone is (650) 324-1832.

Eunjeong Kim's primary practice is Surgery Center Palo Alto in Palo Alto, California. Eunjeong Kim is also affiliated with Stanford Hospital at 300 Pasteur Drive. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Eunjeong Kim to 1 more hospital, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Eunjeong Kim practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Eunjeong Kim's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Eunjeong Kim is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Eunjeong Kim's licenses on file in 3 states: California, Tennessee and Massachusetts.

Dmand AI lists atrial fibrillation and flutter, heart blockage, intermittent racing heartbeat (PSVT), pacemaker or defibrillator implantation, pacemaker replacement, sick sinus syndrome and ventricular tachycardia among the conditions Eunjeong Kim treats.

CMS data shows 819 Medicare services from Eunjeong Kim across 13 procedure codes in 2024, for 337 Medicare patients. Medicare paid $60,806 for them.

CMS counts 337 Medicare patients who saw Eunjeong Kim in 2024. The largest group is 85 and over, with 142 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Eunjeong Kim's median patient age at 76, with 49% women.

In 2024, Eunjeong Kim wrote 579 Medicare Part D claims for 137 patients. 72% of them were for generic drugs. CMS names the drug for 448 of them, across 13 drugs with 11 or more claims each, at $213,280 in total drug cost. In 2023, CMS named 899 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Eunjeong Kim for performance year 2024, reported as part of a group. Eunjeong Kim accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Eunjeong Kim as offering telehealth. CMS counts 27 procedures of pacemaker insertion or repair by Eunjeong Kim, more than 76% of the clinicians it reports for that procedure.

Dmand AI links 14 papers to Eunjeong Kim, published from 2013 to 2022. 2019 was the busiest year, with 2. The most frequent topics are Atrial Fibrillation, Defibrillators, Implantable and Comorbidity. Eunjeong Kim has published most often in Am Heart J. Eunjeong Kim's most frequent co-authors are Roy Mattathu John, MD, George Hinton Crossley, MD and Benjamin Brindley Holmes, MD.

CMS Open Payments shows 276 general payments to Eunjeong Kim from 25 drug and device companies from 2017 to 2025. Grants make up the largest share, 46% of the total. Medtronic Vascular, Inc. paid the most, $32,529.

Eunjeong Kim graduated from Boston University School Of Medicine in 2010.

Eunjeong Kim is in network with 14 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.